SCA
PTLA

Spearhead Capital Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Spearhead Capital Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
2020
Q2 		$330K Buy
2020
Q1 		$96K Buy